Kingsview Wealth Management, LLC Novartis Ag Transaction History

Kingsview Wealth Management, LLC

$5.28 Billion
Q2 2025

A detailed history of Kingsview Wealth Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 7,422 shares of NVS stock, worth $970,574. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,422

Previous 7,272 2.06%

Holding current value

$970,574

Previous $810,000 10.86%

% of portfolio

0.02%

Previous 0.02%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$101.96 - $121.01 $15,293 - $18,151	150 Added 2.06%	7,422 $898,000
Q1 2025 May 02, 2025	SELL	$97.14 - $115.57 $17,290 - $20,571	-178 Reduced 2.39%	7,272 $810,000
Q4 2024 Jan 28, 2025	SELL	$96.78 - $117.18 $21,678 - $26,248	-224 Reduced 2.92%	7,450 $724,000
Q3 2024 Nov 12, 2024	SELL	$106.13 - $120.89 $74,503 - $84,864	-702 Reduced 8.38%	7,674 $882,000
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $62,021 - $71,937	-670 Reduced 7.41%	8,376 $891,000
Q1 2024 May 09, 2024	BUY	$95.27 - $108.47 $49,254 - $56,078	517 Added 6.06%	9,046 $875,000
Q4 2023 Feb 08, 2024	SELL	$92.27 - $101.54 $39,307 - $43,256	-426 Reduced 4.76%	8,529 $861,000
Q3 2023 Nov 07, 2023	BUY	$94.73 - $105.13 $74,552 - $82,737	787 Added 9.64%	8,955 $912,000
Q2 2023 Aug 10, 2023	BUY	$92.52 - $104.91 $99,644 - $112,988	1,077 Added 15.19%	8,168 $824,000
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $48,178 - $55,871	-602 Reduced 7.83%	7,091 $652,000
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $13,750 - $16,838	182 Added 2.42%	7,693 $697,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $12,310 - $14,397	-165 Reduced 2.15%	7,511 $571,000
Q2 2022 Aug 16, 2022	SELL	$80.52 - $93.75 $5,072 - $5,906	-63 Reduced 0.81%	7,676 $649,000
Q1 2022 Feb 08, 2024	SELL	$80.11 - $90.62 $218,219 - $246,848	-2,724 Reduced 31.94%	5,805 $509,000
Q4 2021 Feb 17, 2022	SELL	$79.7 - $88.13 $26,380 - $29,171	-331 Reduced 4.1%	7,739 $677,000
Q3 2021 Dec 03, 2021	BUY	$81.78 - $95.14 $25,433 - $29,588	311 Added 4.01%	8,070 $660,000
Q2 2021 Aug 17, 2021	BUY	$85.24 - $94.15 $71,601 - $79,086	840 Added 12.14%	7,759 $711,000
Q1 2021 May 24, 2021	BUY	$83.5 - $98.47 $63,627 - $75,034	762 Added 12.38%	6,919 $596,000
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $16,550 - $20,019	-212 Reduced 3.33%	6,157 $581,000
Q3 2020 Nov 19, 2020	SELL	$82.14 - $91.0 $92,900 - $102,921	-1,131 Reduced 15.08%	6,369 $554,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $345,247 - $388,632	-4,266 Reduced 36.26%	7,500 $655,000
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $354,551 - $496,733	5,017 Added 74.34%	11,766 $970,000
Q4 2019 Jan 31, 2020	BUY	$84.35 - $95.37 $47,151 - $53,311	559 Added 9.03%	6,749 $639,000
Q4 2019 Jan 30, 2020	BUY	$84.35 - $95.37 $34,583 - $39,101	410 Added 7.09%	6,190 $520,000
Q3 2019 Jan 29, 2020	BUY	$85.54 - $94.26 $26,004 - $28,655	304 Added 5.55%	5,780 $502,000
Q2 2019 Jan 29, 2020	SELL	$75.4 - $92.8 $41,696 - $51,318	-553 Reduced 9.17%	5,476 $500,000
Q1 2019 Jan 29, 2020	BUY	$75.32 - $86.15 $72,985 - $83,479	969 Added 19.15%	6,029 $580,000
Q4 2018 Jan 29, 2020	BUY	$73.66 - $82.02 $4,345 - $4,839	59 Added 1.18%	5,060 $434,000
Q3 2018 Jan 29, 2020	SELL	$66.94 - $77.43 $118,952 - $137,593	-1,777 Reduced 26.22%	5,001 $431,000
Q2 2018 Jan 29, 2020	SELL	$64.91 - $73.36 $3,245 - $3,668	-50 Reduced 0.73%	6,778 $512,000
Q1 2018 Jan 29, 2020	BUY	$70.39 - $84.15 $44,908 - $53,687	638 Added 10.31%	6,828 $552,000
Q4 2017 Jan 29, 2020	BUY	$72.33 - $77.64 $199,920 - $214,596	2,764 Added 80.68%	6,190 $520,000
Q3 2017 Jan 29, 2020	BUY	$74.14 - $77.27 $59,534 - $62,047	803 Added 30.61%	3,426 $294,000
Q2 2017 Jan 29, 2020	BUY	N/A	2,623	2,623 $219,000

Others Institutions Holding NVS

# of Institutions

1,560

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $281B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.

Account

Kingsview Wealth Management, LLC Novartis Ag Transaction History